Reverse transcriptase - PDFSEARCH.IO - Document Search Engine

Reverse transcriptase
Results: 600

#	Item
381	Viread - Nadia Hejazi.pdf Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Tenofovir Emtricitabine Reverse-transcriptase inhibitor Efavirenz Rilpivirine Reverse transcriptase Lamivudine HIV Gilead Sciences Chemistry Organic chemistry
382	serum phosphorus in patients at risk. Avoid administering ATRIPLA with concurrent or recent use of nephrotoxic drugs[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-09-23 12:47:19 Bristol-Myers Squibb Pharmacology Fixed dose combination Organofluorides Non-nucleoside reverse transcriptase inhibitors Emtricitabine/tenofovir/efavirenz Tenofovir Efavirenz Emtricitabine Gilead Sciences Chemistry Organic chemistry
383	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE XR safely and effectively. See full prescribing information for VIRAMUNE XR. VIRAMUNE XR® (nevirapine) ext Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-01-28 14:06:57 Cyclopropanes Lactams Nevirapine Pyridines Organochlorides Etravirine Efavirenz Antiretroviral drug Reverse-transcriptase inhibitor Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
384	HIGHLIGHTS OF PRESCRIBING INFORMATION --------------------------WARNINGS AND PRECAUTIONS-------------------- These highlights do not include all the information needed to use VIREAD safely and effectively. See full p Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-08-20 14:33:59 Organic chemistry Pharmacology Organofluorides Fixed dose combination Purines Tenofovir Reverse-transcriptase inhibitor Emtricitabine/tenofovir/efavirenz Efavirenz Gilead Sciences Chemistry Bristol-Myers Squibb
385	HIGHLIGHTS OF PRESCRIBING INFORMATION --------------------------WARNINGS AND PRECAUTIONS--------------------- These highlights do not include all the information needed to use VIREAD safely and effectively. See full pre Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-04-09 13:51:08 Organic chemistry Pharmacology Organofluorides Fixed dose combination Purines Tenofovir Reverse-transcriptase inhibitor Emtricitabine/tenofovir/efavirenz Efavirenz Gilead Sciences Chemistry Bristol-Myers Squibb
386	APPENDIX I THE PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF SOURCES OF FUNDING (Dollars in Millions) Add to Reading List Source URL: www.pepfar.gov Language: English - Date: 2014-09-01 00:42:39 Bristol-Myers Squibb Organofluorides Medicine Purines Non-nucleoside reverse transcriptase inhibitors Lamivudine Cipla Abacavir Nevirapine Chemistry Organic chemistry Cyclopropanes
387	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. Viramune® (nevirapine) tablets 200 Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-01-20 12:04:30 Cyclopropanes Piperazines Tuberculosis Lactams Nevirapine Efavirenz Antiretroviral drug Norfloxacin Methadone Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
388	HIGHLIGHTS OF PRESCRIBING INFORMATION • New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess creatinine clearance Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-07-30 15:02:53 Organic chemistry Pharmacology Organofluorides Fixed dose combination Purines Tenofovir Reverse-transcriptase inhibitor Emtricitabine/tenofovir/efavirenz Efavirenz Gilead Sciences Chemistry Bristol-Myers Squibb
389	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-12-10 17:41:28 Carbamates Protease inhibitors Pyrimidines Nitriles Rilpivirine Efavirenz Darunavir Etravirine Reverse-transcriptase inhibitor Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
390	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ® Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-12-23 12:58:35 Gilead Sciences Carbamates Non-nucleoside reverse transcriptase inhibitors Integrase inhibitors Raltegravir Tenofovir Efavirenz Darunavir Antiretroviral drug Chemistry Organic chemistry Organofluorides

UPDATE